Search Results - "Bremner, K.E"

Cost-effectiveness of Intensity-modulated Radiotherapy in Prostate Cancer by Yong, J.H.E, Beca, J, McGowan, T, Bremner, K.E, Warde, P, Hoch, J.S

“…Abstract Aims To compare the costs and effectiveness of intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy (3DCRT) for the…”
Get full text

Quality of life and utility measurement in bladder cancer patients by Papasideris, M., Bremner, K.E., Cheung, D.C., Black, P.C., Kassouf, W., Wong, W.L., Kulkarni, G.S.

Get full text

A0356 - Quality of life and utility measurement in bladder cancer patients by Papasideris, M., Bremner, K.E., Cheung, D.C., Black, P.C., Kassouf, W., Wong, W.L., Kulkarni, G.S.

Get full text

A0368 - Development of the Bladder Utility Symptom Scale (BUSS utility): A novel tool to measure utilities and quality of life in bladder cancer patients by Kulkarni, G., Perlis, N., Cheung, D., Bremner, K.E., Papasideris, M., Lajkosz, K., Power, N., Nam, R.K., Tomlinson, G.

Get full text

Development of the Bladder Utility Symptom Scale (BUSS utility): A novel tool to measure utilities and quality of life in bladder cancer patients by Kulkarni, G., Perlis, N., Cheung, D., Bremner, K.E., Papasideris, M., Lajkosz, K., Power, N., Nam, R.K., Tomlinson, G.

Get full text

Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events by Krahn, M D, Bremner, K E, Luo, J, Alibhai, S M H

“…Serious adverse events have been associated with androgen deprivation therapy (adt) for prostate cancer (pca), but few studies address the costs of those…”
Get full text

Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS) by Bremner, K.E, Mitsakakis, N, Wilson, L, Krahn, M.D

Get full text

Population-based trends in systemic therapy use and cost for cancer patients in the last year of life by Pataky, R E, Cheung, W Y, de Oliveira, C, Bremner, K E, Chan, K K W, Hoch, J S, Krahn, M D, Peacock, S J

“…The use of systemic therapy near the end of life can expose cancer patients to severe toxicity for minimal survival gain and comes with a high cost. Early…”
Get full text

Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS) by Bremner, K E, Mitsakakis, N, Wilson, L, Krahn, M D

“…Background: The Prostate Cancer Index (PCI) is a health profile instrument that measures health-related quality of life with six subscales: urinary, sexual,…”
Get full text

Long-term health care costs for prostate cancer patients on androgen deprivation therapy by Krahn, M D, Bremner, K E, Luo, J, Tomlinson, G, Alibhai, S M H

“…Comparing relative costs for androgen deprivation therapy (adt) protocols in prostate cancer (pca) requires an examination of all health care resources, not…”
Get full text

Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy by Krahn, M D, Bremner, K E, Tomlinson, G, Naglie, G

“…This study aims to examine and compare changes in quality of life after two common treatments for prostate cancer (PC), radical prostatectomy (RP) and…”
Get full text

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems by Naranjo, C A, Bremner, K E, Lanctôt, K L

“…Citalopram (C) decreased alcohol intake and desire to drink in short-term (2-4 weeks) studies with no other treatment. We tested the long-term effects of C…”
Get more information